Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Open, Multicenter Study of BEBT-209 in Women With Advanced Breast Cancer

NCT06047184 is registered in ClinicalTrials.gov with BeBetter Med Inc as lead sponsor.

NCT NCT06047184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06047184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Open, Multicenter Study of BEBT-209 in Women With Advanced Breast Cancer
Lead sponsor
BeBetter Med Inc
Phase
Phase 1
Overall status
Completed
Start date
July 15, 2019
Completion date
January 30, 2024
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer